It would thus be of great interest to investigate whether hepatic PPARα stimulation with pemafibrate or GW7647, well known PPARα agonists, in the absence of HIF1α in hepatocytes during sepsis might be able to restore PPARα functioning and reduce lipotoxicity. Here, HIF1A is linked to Sepsis.